Circio Holding ASA

Price Chart

Risk-Adjusted Performance

Also Listed On

Circio Holding ASA (CRNA) Price Performance

Circio Holding ASA (CRNA) trades on Oslo Stock Exchange in NOK. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at NOK8.35, down 7.22% from the previous close.

Over the past year, CRNA has traded between a low of NOK0.57 and a high of NOK14.40. The stock has gained 1108.4% over this period. It is currently 42.0% below its 52-week high.

Circio Holding ASA has a market capitalization of $2.04B.

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. The company was incorporated in 2010 and is based in Oslo, Norway.

Compare Circio Holding ASA

Side-by-side comparison against top Healthcare peers.